Weidong Gan

1.1k total citations
74 papers, 687 citations indexed

About

Weidong Gan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Weidong Gan has authored 74 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pulmonary and Respiratory Medicine, 47 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Weidong Gan's work include Renal cell carcinoma treatment (42 papers), Renal and related cancers (36 papers) and Bladder and Urothelial Cancer Treatments (17 papers). Weidong Gan is often cited by papers focused on Renal cell carcinoma treatment (42 papers), Renal and related cancers (36 papers) and Bladder and Urothelial Cancer Treatments (17 papers). Weidong Gan collaborates with scholars based in China, Hong Kong and Italy. Weidong Gan's co-authors include Hongqian Guo, Dongmei Li, Xiaodong Han, Xiaogong Li, Gutian Zhang, Zou Xiang, Xiaozhi Zhao, Changwei Ji, Xiancheng Chen and Feng Qu and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Urology.

In The Last Decade

Weidong Gan

67 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weidong Gan China 16 444 399 182 153 52 74 687
Su Xie China 8 246 0.6× 227 0.6× 116 0.6× 60 0.4× 43 0.8× 27 562
Libin Yan China 17 380 0.9× 233 0.6× 191 1.0× 38 0.2× 95 1.8× 29 640
Wioletta Skrońska-Wąsek Germany 10 240 0.5× 417 1.0× 55 0.3× 104 0.7× 59 1.1× 14 712
Hanna Kim South Korea 9 327 0.7× 113 0.3× 158 0.9× 56 0.4× 50 1.0× 21 600
Daxiong Zeng China 16 270 0.6× 273 0.7× 177 1.0× 60 0.4× 108 2.1× 47 624
Nanor Sirab France 10 274 0.6× 257 0.6× 90 0.5× 72 0.5× 94 1.8× 14 628
Sijing Zhou China 17 362 0.8× 327 0.8× 295 1.6× 42 0.3× 151 2.9× 60 742
Jia‐Bin Wang China 16 318 0.7× 170 0.4× 232 1.3× 114 0.7× 139 2.7× 35 637
Motoyuki Masai Japan 19 320 0.7× 686 1.7× 153 0.8× 102 0.7× 104 2.0× 62 1.0k
Weidong Gan China 14 243 0.5× 261 0.7× 103 0.6× 96 0.6× 42 0.8× 32 434

Countries citing papers authored by Weidong Gan

Since Specialization
Citations

This map shows the geographic impact of Weidong Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong Gan more than expected).

Fields of papers citing papers by Weidong Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weidong Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong Gan. The network helps show where Weidong Gan may publish in the future.

Co-authorship network of co-authors of Weidong Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Weidong Gan. A scholar is included among the top collaborators of Weidong Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weidong Gan. Weidong Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Yao, Giancarlo Marra, Feifei Zhang, et al.. (2024). Modified Retzius-sparing robot-assisted radical prostatectomy for cases with anterior tumor: a propensity score-matched analysis. World Journal of Urology. 42(1). 170–170.
2.
Yang, Yang, Wei Chen, Hongwei Shen, et al.. (2024). GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A. International Journal of Biological Sciences. 20(4). 1297–1313. 4 indexed citations
4.
Chen, Yi, Yanwen Lu, Lei Yang, et al.. (2023). LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-TFE3 rearranged renal cell carcinoma in an NAD+ kinase-independent manner. Journal of Experimental & Clinical Cancer Research. 42(1). 252–252. 9 indexed citations
5.
Zhou, Shuoming, Yanwen Lu, Yuxin Chen, & Weidong Gan. (2023). Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma. Scientific Reports. 13(1). 4449–4449. 2 indexed citations
6.
Ma, Wenliang, Haifeng Huang, Wei Wang, et al.. (2022). Contrast‐Enhanced Ultrasound Features of Adult Xp11.2 Translocation Renal Cell Carcinoma. Journal of Ultrasound in Medicine. 41(11). 2673–2685. 4 indexed citations
7.
Dong, Xiang Da, Yuxin Chen, Jun Pan, et al.. (2022). Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma. Frontiers in Oncology. 12. 1017425–1017425. 4 indexed citations
8.
Yang, Lei, Yi Chen, Chun Pan, et al.. (2022). Low expression of PEBP1P2 promotes metastasis of clear cell renal cell carcinoma by post-transcriptional regulation of PEBP1 and KLF13 mRNA. Experimental Hematology and Oncology. 11(1). 87–87. 12 indexed citations
9.
Yang, Lei, Yi Chen, Ning Liu, et al.. (2021). Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N6-methyladenosine of PARP1 mRNA and downregulating PTEN. Journal of Hematology & Oncology. 14(1). 144–144. 47 indexed citations
10.
Wang, Bo, Xiaoqin Yin, Weidong Gan, et al.. (2020). PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma. Autophagy. 17(9). 2475–2493. 26 indexed citations
11.
Zhang, Ling, Weidong Gan, Kai Fu, et al.. (2019). piRNA‐DQ722010 contributes to prostate hyperplasia of the male offspring mice after the maternal exposed to microcystin‐leucine arginine. The Prostate. 79(7). 798–812. 15 indexed citations
13.
Gan, Weidong, Feng Qu, Zhen Wang, et al.. (2018). Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?. American Journal Of Pathology. 188(4). 929–936. 8 indexed citations
14.
Qu, Feng, Jing Sun, Wei Xu, et al.. (2018). Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients. BMC Urology. 18(1). 60–60. 12 indexed citations
15.
Wang, Zhen, Weidong Gan, Lei Xiong, et al.. (2016). Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis. PLoS ONE. 11(11). e0166897–e0166897. 30 indexed citations
16.
Qu, Feng, Zhenlei Zha, Kefeng Zhou, et al.. (2015). CT-guided percutaneous radiofrequency ablation for adrenocortical adenoma with Cushing's syndrome. 9(6). 444–448.
17.
He, Jian, Weidong Gan, Song Liu, et al.. (2015). Dynamic Computed Tomographic Features of Adult Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene Fusions. Journal of Computer Assisted Tomography. 39(5). 730–736. 20 indexed citations
18.
Xu, Linfeng, Rong Yang, Wei Wang, Yifen Zhang, & Weidong Gan. (2014). Laparoscopic radiofrequency ablation-assisted enucleation of Xp11.2 translocation renal cell carcinoma: A case report. Oncology Letters. 8(3). 1237–1239. 3 indexed citations
19.
Lian, Huibo, Weidong Gan, Xiaogong Li, et al.. (2010). Retroperitoneoscopic cryoablation for small renal tumors: a preliminary report. Zhonghua miniao waike zazhi. 31(6). 369–372. 1 indexed citations
20.
Lian, Huibo, Hongqian Guo, Weidong Gan, et al.. (2009). Comparison of clinical efficacy in the treatment of renal cell carcinoma: laparoscopic cool-tip radiofrequency ablation vs partial nephrectomy. Zhonghua miniao waike zazhi. 30(11). 731–734. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026